Patent US2031594A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5124332A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted indoles as central nervous system agents

Assignee: Warner Lambert Co LLC
•
Filing: 1991-01-28
•
Granted: 1992-06-23
•
Expires: 2011-01-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Substituted indoles and derivatives thereof are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.

Inventors

  • 👤 Lawrence D. Wise
  • 👤 David J. Wurtrow

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 12:30
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/08; C07D401/14; C07D409/00; C07D409/14

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 407 words
A compound of Formula I: ##STR46## wherein R is ##STR47## wherein R 4 is aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR48## wherein R 5 is lower alkyl, halogen, or trifluoromethyl, 2-k 3-, or 4-pyridinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR49## wherein R 5 is as defined above, 2-, 4-, or 5-pyrimidinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR50## wherein R 5 is as defined above, 2-pyrazinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR51## wherein R 5 is as defined above, 2- or 3-furanyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR52## wherein R 5 is as defined above, 2-, or 3-thienyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR53## wherein R 5 is as defined above, 2-, 4-, or 5-imidazolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR54## wherein R 5 is as defined above, 2-, 4-, or 5-thiazolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR55## wherein R 5 is as defined above, or 2-, 3-, 4-, 5-, 6-, or 7-indolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR56## wherein R 5 is as defined above; R 1 is hydrogen, --CN, or --CO 2 H; R 2 is hydrogen, lower alkyl, or cycloalkyl; R 3 is hydrogen, halogen, hydroxyl, lower alkoxy, lower alkyl, ##STR57## wherein R 6 is hydrogen or lower alkyl, ##STR58## wherein R 7 is hydrogen, lower alkyl, cycloalkyl, or aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR59## wherein R 5 is as defined above, halogen, or trifluoromethyl, ##STR60## wherein R 8 is lower alkyl, cycloalkyl or aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR61## wherein R 5 is as defined above, halogen, or trifluoromethyl, or --NH 2 ; n is zero or an integer of 1, 2, or 3; is a single or double bond; and corresponding geometric isomers thereof; or a pharmaceutically acceptable acid or base addition salt thereof.
Claim 2
Dependent Claim 407 words
A compound of Formula I: ##STR46## wherein R is ##STR47## wherein R 4 is aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR48## wherein R 5 is lower alkyl, halogen, or trifluoromethyl, 2-k 3-, or 4-pyridinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR49## wherein R 5 is as defined above, 2-, 4-, or 5-pyrimidinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR50## wherein R 5 is as defined above, 2-pyrazinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR51## wherein R 5 is as defined above, 2- or 3-furanyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR52## wherein R 5 is as defined above, 2-, or 3-thienyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR53## wherein R 5 is as defined above, 2-, 4-, or 5-imidazolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR54## wherein R 5 is as defined above, 2-, 4-, or 5-thiazolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR55## wherein R 5 is as defined above, or 2-, 3-, 4-, 5-, 6-, or 7-indolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR56## wherein R 5 is as defined above; R 1 is hydrogen, --CN, or --CO 2 H; R 2 is hydrogen, lower alkyl, or cycloalkyl; R 3 is hydrogen, halogen, hydroxyl, lower alkoxy, lower alkyl, ##STR57## wherein R 6 is hydrogen or lower alkyl, ##STR58## wherein R 7 is hydrogen, lower alkyl, cycloalkyl, or aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR59## wherein R 5 is as defined above, halogen, or trifluoromethyl, ##STR60## wherein R 8 is lower alkyl, cycloalkyl or aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR61## wherein R 5 is as defined above, halogen, or trifluoromethyl, or --NH 2 ; n is zero or an integer of 1, 2, or 3; is a single or double bond; and corresponding geometric isomers thereof; or a pharmaceutically acceptable acid or base addition salt thereof.
Claim 3
Dependent Claim 68 words
A compound according to claim 1, in which R 4 is aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR62## wherein R 5 is lower alkyl, halogen, or trifluoromethyl, 2-, 3-, or 4-pyridinyl, 2-, 4-, or 5-pyrimidinyl, 2-, or 3-furanyl, 2-, or 3-thienyl, 2-, 4-, or 5-thiazolyl, or 2-, 3-, 4-, 5-, 6-, or 7-indolyl,.
Claim 4
Dependent Claim 38 words
A compound according to claim 2, in which R 4 is aryl, 2-, 3-, or 4-pyridinyl, 2-, 4-, or 5-pyrimidinyl, 2-, or 3-furanyl, 2-, or 3-thienyl, 2-, 4-, or 5-thiazolyl, or 2-, 3-, 4-, 5-, 6-, or 7-indolyl.
Claim 5
Dependent Claim 56 words
A compound according to claim 1 selected from the group consisting of: Trans 3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Cis 3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Trans 3-[4-[2-[4-(2-pyrimidinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole, hydrochloride; Cis 3-[4-[2-(2-pyrimidinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole, hydrochloride; Trans 3-[4-[2-(3,6-dihydro-4-phenyl-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole; Cis 3-[4-[2-(3,6-dihydro-4-phenyl-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole; Trans 3-[4-[2-(3,6-dihydro-4-(2-thienyl)-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole; Cis 3-[4-[2-(3,6-dihydro-4-(2-thienyl)-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole. Trans 3-[4-[2-(3,6-dihydro-4-(2-pyridinyl)-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole. Cis 3-[4-[2-(3,6-dihydro-4-(2-pyridinyl)-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole; Trans 5-methoxy-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole. Cis 5-methoxy-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Trans 5-fluoro-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Cis 5-fluoro-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Trans 3-[4-[4-(2-pyridinyl)-1-piperazinylmethyl]cyclohexyl]-1H-indole; Cis 3-[4-[4-(2-pyridinyl)-1-piperazinylmethyl]cyclohexyl]-1H-indole. 3-[4-[2-[4-[(2-Pyridinyl)-1-piperazinyl]ethyl]cyclohexen-1-yl]-1H-indole; Trans 3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indol-5-ol; Cis 3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indol-5-ol; Trans 1-methyl-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; and Cis 1-methyl-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole.
Claim 6
Dependent Claim 27 words
A method of treating schizophrenia comprising administering to a host suffering therefrom a therapeutic effective amount of a compound according to claim 1 in unit dosage form.
Claim 7
Dependent Claim 27 words
A method of treating depression comprising administering to a host suffering therefrom a therapeutic effective amount of a compound according to claim 1 in unit dosage form.
Claim 8
Dependent Claim 35 words
A pharmaceutical composition adapted for administration as a dopaminergic, antipsychotic, or antidepressant agent comprising a therapeutic effective amount of a compound according to claim 1 in admixture with a pharmaceutically acceptable excipient, diluent, or carrier.

References Cited (Backward Citations)

EP0345808A1 Cited
US4954502A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-06-23 1995-12-23 1996-06-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-06-23 1999-12-23 2000-06-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-06-23 2003-12-23 2004-06-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag